BISMUL
-
Chemical Name:
Bismuth subcitrate -
Therapeutic Category:
Gastro-intestinal drugs -
Pharmacologic Category:
Anti-Ulcer -
Pharmaceutical Form:
Tablets -
Composition:
Bismuth subcitrate eq. Bi2O3 300mg
BISMUL
Film Coated Tablets
Bismuth Subcitrate
For Peptic & Duodenal Ulcers
1-PROPERTIES:
BISMUL is a bismuth subcitrate, in an aqueous solution, the dried complex becomes colloidal. In the acid environment of the stomach it forms a white precipitate mainly of bismuth compound. The precipitate binds to proteins at ulcer sites and forms complexes with mucus, so providing a local protective layer, which heals peptic and duodenal ulcer. BISMUL has a bactericidal effect against helicobacter pylori that causes duodenal ulcer.
2-INDICATIONS:
BISMUL is used in the treatment of :
- Peptic and duodenal ulcers.
- Gastritis.
3-CONTRAINDICATIONS:
- Patients with renal disorders.
- Pregnancy and lactation.
4-PRECAUTIONS:
Long-term therapy is not recommended.
5-SIDE EFFECTS:
Nausea, vomiting, darkening of the tongue, blackening of the feces.
Possibility of encephalopathy following overdosage or long-term therapy.
6-DRUG INTERACTIONS:
- BISMUL should not be taken at the same time with antacids or milk.
- BISMUL inhibits the efficacy of tetracyclines taken by mouth.
7-DOSAGE & ADMINISTRAION:
The usual dosage is: 2 tablets twice daily or 1 tablets four times daily taken before food for 4 weeks extended to 8 weeks if necessary.
Treatment may be repeated after a drug free interval of one month.
8-PACKAGING & COMPOSITION:
BISMUL - F.C.Tablets: A pack of 20 or 24 or 120 f.c. tablets. Each f.c.tablet contains 120 mg Bi2O3 (as Subcitrate).
9-STORAGE CONDITIONS:
Store BISMUL - F.C.Tablets at temperature below 25C.